Search Result "PI3K/AKT/mTOR signalingpathway."
PI3K/Akt/mTOR Pathway in Acute Lymphoblastic Leukemia Targeted Therapies
Ebook: Frontiers in Anti-Cancer Drug Discovery
Volume: 11 Year: 2020
Author(s): Carolina Simioni,Giorgio Zauli,Daniela Milani,Luca M. Neri
Doi: 10.2174/9789811422133120110003
Effect of PI3K/AKT/mTOR Signaling Pathway on Regulating and Controlling the Anti-Invasion and Metastasis of Hepatoma Cells by Bufalin
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 16 Issue: 1 Year: 2021 Page: 54-65
Author(s): Xia Sheng,Pengfei Zhu,Yi Zhao,Jinwei Zhang,Haijia Li,Huan Zhao,Jianmin Qin
Cucurbitacin D Inhibits the Proliferation of HepG2 Cells and InducesApoptosis by Modulating JAK/STAT3, PI3K/Akt/mTOR and MAPK SignalingPathways
Journal: Current Cancer Drug Targets
Volume: 22 Issue: 11 Year: 2022 Page: 931-944
Author(s):
Targeted Regulation of PI3K/Akt/mTOR/NF-κB Signaling by Indole Compounds and their Derivatives: Mechanistic Details and Biological Implications for Cancer Therapy
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13 Issue: 7 Year: 2013 Page: 1002-1013
Author(s): Aamir Ahmad, Bernhard Biersack, Yiwei Li, Dejuan Kong, Bin Bao, Rainer Schobert, Subhash B. Padhye, Fazlul H. Sarkar
Anti-Cancer Role of Dendrosomal Nano Solanine in Chronic MyelogenousLeukemia Cell Line through Attenuation of PI3K/AKT/mTOR SignalingPathway and Inhibition of hTERT Expression
Journal: Current Molecular Pharmacology
Volume: 16 Issue: 5 Year: 2023 Page: 592-608
Author(s): Seyedeh Sahar Mortazavi Farsani
Vitamin D Affects the Warburg Effect and Stemness Maintenance of Non-Small-Cell Lung Cancer Cells by Regulating the PI3K/AKT/mTOR SignalingPathway
Journal: Current Cancer Drug Targets
Volume: 22 Issue: 1 Year: 2022 Page: 86-95
Author(s): Songyisha Yang,Dejia Li,Wen Li
Current Status and Future Perspectives of PI3K and mTOR Inhibitor as Anticancer Drugs in Breast Cancer
Journal: Current Cancer Drug Targets
Volume: 13 Issue: 2 Year: 2013 Page: 175-187
Author(s): Xiaobei Zhang, Xi-ru Li, Jin Zhang
MicroRNA3650 Promotes Gastric Cancer Proliferation and Migrationthrough the PTEN/PI3K-AKT-mTOR and Hippo Pathways
Journal: Protein & Peptide Letters
Volume: 30 Issue: 11 Year: 2023 Page: 966-973
Author(s):
Network Analysis and Basic Experiments on the Inhibition of RenalCancer Proliferation and Migration by Alpinetin through PI3K/AKT/mTOR Pathway
Journal: Current Molecular Medicine
Volume: 24 Issue: 1 Year: 2024 Page: 134-144
Author(s):
Targeting Drug-Resistant Prostate Cancer with Dual PI3K/mTOR Inhibition
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 26 Year: 2014 Page: 3048-3056
Author(s): K.D. Tang,Ming-Tat Ling